🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, multi-center, dose-escalation trial of pimasertib (M...
Status
Terminated
Location
Northwestern University
Start Date
2009-09-30
Trial ID
NCT00957580
Treatments Being Tested
Primary Objective: \- To determine the maximum tolerated dose(s) (MTD) and...
Status
Completed
Location
Investigational Site Number 840001
Start Date
2011-05
Trial ID
NCT01357330
Treatments Being Tested
This research trial is testing a combination of two experimental drugs, MSC...
Status
Completed
Location
Pinnacle Oncology Hematology
Start Date
2011-05
Trial ID
NCT01390818
The research trial is testing the experimental treatment pimasertib (MSC193...
Status
Terminated
Location
Research Site
Start Date
2010-03
Trial ID
NCT01085331
Treatments Being Tested
This is a first in man trial with a primary objective being the determinati...
Status
Completed
Location
Westmead Hospital
Start Date
2007-12-31
Trial ID
NCT00982865
Treatments Being Tested
The research trial is testing the experimental treatment MSC1936369B in com...
Status
Completed
Location
For Recruiting Locations in the United States, please Contact U.S. Medical Information
Start Date
2009-11-30
Trial ID
NCT01016483
Treatments Being Tested
This is a Phase 2, multicenter, randomized, controlled, open-label trial of...
Status
Completed
Location
Research Site
Start Date
2012-12-05
Trial ID
NCT01693068
Treatments Being Tested
This is a Phase 1, multi-center, open-label, single-dose, 2 period, 2 seque...
Status
Completed
Location
Please Contact U.S. Medical Information Located in
Start Date
2013-11-30
Trial ID
NCT01992874
The research trial is testing the experimental drug pimasertib and the drug...
Status
Terminated
Location
Cedars-Sinai Medical Center
Start Date
2011-05-27
Trial ID
NCT01378377
Treatments Being Tested
This phase I/II trial studies the best dose and effect of pimasertib in com...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2021-01-15
Trial ID
NCT04789668
Treatments Being Tested